MedMira Inc. MIR.V
TSX
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 47.73% | -32.69% | -36.69% | -43.34% | -35.60% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 47.73% | -32.69% | -36.69% | -43.34% | -35.60% |
| Cost of Revenue | -9.07% | -14.77% | -17.49% | -13.52% | -0.80% |
| Gross Profit | 29.77% | 7.56% | 7.11% | -6.48% | -23.59% |
| SG&A Expenses | -37.07% | -31.66% | -5.60% | 5.91% | 50.27% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -40.93% | -33.28% | -3.93% | 25.02% | 52.70% |
| Operating Income | 46.95% | 33.33% | 0.07% | -36.01% | -68.38% |
| Income Before Tax | 35.15% | 22.31% | -2.00% | -32.75% | -44.96% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 35.15% | 22.31% | -2.00% | -32.75% | -44.96% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 35.15% | 22.31% | -2.00% | -32.75% | -44.96% |
| EBIT | 46.95% | 33.33% | 0.07% | -36.01% | -68.38% |
| EBITDA | 49.97% | 35.91% | 1.31% | -36.01% | -71.01% |
| EPS Basic | 35.42% | 21.74% | -2.50% | -38.24% | -50.00% |
| Normalized Basic EPS | 36.67% | 24.14% | -4.00% | -31.82% | -50.00% |
| EPS Diluted | 38.89% | 30.77% | 4.44% | -31.58% | -42.11% |
| Normalized Diluted EPS | 36.67% | 24.14% | -4.00% | -31.82% | -50.00% |
| Average Basic Shares Outstanding | 0.26% | 0.26% | 0.39% | 0.55% | 0.17% |
| Average Diluted Shares Outstanding | 0.26% | 0.26% | 0.39% | 0.55% | 0.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |